Hinge Health, Inc. (HNGE)
89.98
+1.56
(+1.76%)
USD |
NYSE |
Aug 24, 16:00
91.15
+1.17
(+1.30%)
After-Hours: 20:00
Hinge Health Gross Profit Margin (Quarterly) : 86.44% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 86.44% |
| March 31, 2026 | 84.60% |
| December 31, 2025 | 84.36% |
| September 30, 2025 | 81.84% |
| June 30, 2025 | 70.28% |
| March 31, 2025 | 80.95% |
| December 31, 2024 | 81.95% |
| Date | Value |
|---|---|
| September 30, 2024 | 78.77% |
| June 30, 2024 | 74.16% |
| March 31, 2024 | 70.05% |
| December 31, 2023 | 71.73% |
| September 30, 2023 | 71.44% |
| June 30, 2023 | 62.49% |
| March 31, 2023 | 56.56% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| West Pharmaceutical Services, Inc. | 37.83% |
| Vivos Therapeutics, Inc. | 47.41% |
| Globus Medical, Inc. | 65.92% |
| Exlites Holdings International, Inc. | 0.00% |
| Xcelerate, Inc. | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 29.28% |
| Return on Assets | 14.12% |
| Return on Invested Capital | 28.65% |
| Profit Margin (Quarterly) | 20.25% |
| Operating Margin (Quarterly) | 19.21% |
| Return on Net Operating Assets | 41.82% |